ArticleOncoimmunology2023

Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma.

Jorge D Oldan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.